Lucira Health, Inc.
LHDXDelisted Apr 12, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652724
Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Lucira Health, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +10 vs. Q3 2021
- Shares held
- 24.6M
- +6.84M (+38.6%) vs. Q3 2021
- Total value
- $211.6M
- +$79.8M (+60.5%) vs. Q3 2021
- New holders
- 20
- 12 more added
- Sold out
- 10
- 7 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LHDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $321 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $545 |
| Q1 2023 | 6 | $1.46M |
| Q4 2022 | 29 | $1.04M |
| Q3 2022 | 28 | $24.2M |
| Q2 2022 | 38 | $42.2M |
| Q1 2022 | 40 | $83.7M |
| Q4 2021 | 46 | $211.6M |
| Q3 2021 | 36 | $131.9M |
| Q2 2021 | 44 | $107.9M |
| Q1 2021 | 51 | $233.6M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Lucira Health, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EPIQ Capital Group, LLC | 13,996,250 | $120.5M | 21.41% | +200,067+1.5% | Added |
| Eclipse Ventures, LLC | 6,223,795 | $53.6M | 8.95% | +6,223,795 | New |
| Pura Vida Investments, LLC | 1,165,230 | $10.0M | 1.05% | +163,288+16.3% | Added |
| Silverarc Capital Management, LLC | 515,000 | $4.43M | 1.99% | +294,242+133.3% | Added |
| Vanguard Group Inc | 511,838 | $4.41M | 0.00% | +63,384+14.1% | Added |
| Millennium Management LLC | 446,301 | $3.84M | 0.00% | +225,317+102.0% | Added |
| Data Collective II GP, LLC | 296,227 | $2.55M | 2.66% | +296,227 | New |
| Parian Global Management LP | 183,804 | $1.58M | 1.43% | +183,804 | New |
| Susquehanna International Group, LLP | 164,512 | $1.42M | 0.00% | +56,541+52.4% | Added |
| Consilio Wealth Advisors, LLC | 97,518 | $840.0K | 0.65% | +97,518 | New |
| Geode Capital Management, LLC | 93,436 | $804.0K | 0.00% | +9,349+11.1% | Added |
| Wells Fargo & Company | 80,387 | $692.0K | 0.00% | −494−0.6% | Reduced |
| D. E. Shaw & Co., Inc. | 74,565 | $642.0K | 0.00% | +74,565 | New |
| Ieq Capital, LLC | 73,205 | $630.0K | 0.01% | +27,030+58.5% | Added |
| Qube Research & Technologies Ltd | 64,729 | $557.0K | 0.00% | +64,729 | New |
| Simplex Trading, LLC | 60,932 | $524.0K | 0.02% | +60,889+141,602.3% | Added |
| Atom Investors LP | 55,479 | $478.0K | 0.13% | +55,479 | New |
| State Street Corp | 49,500 | $426.0K | 0.00% | 00.0% | Unchanged |
| Papp L Roy & Associates | 45,500 | $392.0K | 0.04% | −350−0.8% | Reduced |
| BlackRock Inc. | 43,337 | $373.0K | 0.00% | −10,824−20.0% | Reduced |
| 683 Capital Management, LLC | 41,629 | $358.0K | 0.02% | +41,629 | New |
| Citadel Advisors LLC | 35,544 | $306.0K | 0.00% | −15,838−30.8% | Reduced |
| Cutler Group LP | 28,272 | $243.0K | 0.02% | +26,872+1,919.4% | Added |
| Resolute Partners Group | 22,800 | $196.0K | 0.01% | 00.0% | Unchanged |
| CastleKnight Management LP | 22,800 | $196.0K | 0.07% | +22,800 | New |
| Northern Trust Corp | 17,414 | $150.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 17,400 | $150.0K | 0.00% | +7,200+70.6% | Added |
| Tudor Investment Corp Et Al | 15,629 | $135.0K | 0.00% | +15,629 | New |
| Cypress Point Wealth Management, LLC | 14,177 | $122.0K | 0.11% | 00.0% | Unchanged |
| Paloma Partners Management Co | 13,084 | $113.0K | 0.00% | +13,084 | New |
| Morgan Stanley | 12,558 | $109.0K | 0.00% | −1,415−10.1% | Reduced |
| Man Group plc | 12,669 | $109.0K | 0.00% | +12,669 | New |
| ETF Managers Group, LLC | 11,855 | $106.0K | 0.00% | −2,275−16.1% | Reduced |
| Royal Bank of Canada | 11,660 | $100.0K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 11,300 | $97.0K | 0.00% | +11,300 | New |
| TrinityPoint Wealth, LLC | 11,000 | $95.0K | 0.02% | −3,250−22.8% | Reduced |
| Walleye Capital LLC | 10,915 | $94.0K | 0.00% | +10,915 | New |
| Johnson Financial Group, Inc. | 10,000 | $86.0K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 9,582 | $83.0K | 0.00% | +9,582 | New |
| Group One Trading, L.P. | 4,103 | $35.0K | 0.00% | +4,103 | New |
| UBS Group AG | 1,772 | $15.0K | 0.00% | +625+54.5% | Added |
| JPMorgan Chase & Co | 463 | $4.00K | 0.00% | +463 | New |
| Captrust Financial Advisors | 319 | $3.00K | 0.00% | 00.0% | Unchanged |
| Snowden Capital Advisors LLC | 340 | $2.00K | 0.00% | +340 | New |
| Tower Research Capital LLC (TRC) | 169 | $1.00K | 0.00% | +169 | New |
| Advisor Group Holdings, Inc. | 50 | $0 | 0.00% | +50 | New |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −578,114−100.0% | Sold out |
| Board of Trustees of The Leland Stanford Junior University | 0 | $0 | 0.00% | −124,459−100.0% | Sold out |
| Foresite Capital Management V, LLC | 0 | $0 | 0.00% | −485,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −93,439−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −57,684−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −27,487−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −15,331−100.0% | Sold out |
| Needham Investment Management LLC | 0 | $0 | 0.00% | −13,672−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −215−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −40−100.0% | Sold out |